Non-enzymatic glycation alters microdamage formation in human cancellous bone. - Wikidata - awgldk - TriplyDB

Non-enzymatic glycation alters microdamage formation in human cancellous bone.

Non-enzymatic glycation alters microdamage formation in human cancellous bone.

http://www.wikidata.org/entity/Q35429148

about

Multiscale imaging of bone microdamage Heterogeneous glycation of cancellous bone and its association with bone quality and fragility N-phenacylthiazolium bromide reduces bone fragility induced by nonenzymatic glycation Effect of age on mechanical properties of the collagen phase in different orientations of human cortical bone Effects of trabecular type and orientation on microdamage susceptibility in trabecular bone.Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales.Determinants of microdamage in elderly human vertebral trabecular bone Nanoscale examination of microdamage in sheep cortical bone using synchrotron radiation transmission x-ray microscopy.The effects of tensile-compressive loading mode and microarchitecture on microdamage in human vertebral cancellous bone.Role of trabecular microarchitecture in the formation, accumulation, and morphology of microdamage in human cancellous bone.Focal therapeutic irradiation induces an early transient increase in bone glycation.RAGE, receptor of advanced glycation endoproducts, negatively regulates chondrocytes differentiation Fatigue-induced microdamage in cancellous bone occurs distant from resorption cavities and trabecular surfaces Mechanical failure begins preferentially near resorption cavities in human vertebral cancellous bone under compression.Skin advanced glycation end-product accumulation is negatively associated with calcaneal osteo-sono assessment index among non-diabetic adult Japanese men.Association between non-enzymatic glycation, resorption, and microdamage in human tibial cortices.Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance.Hip geometry in diabetic women: implications for fracture risk.A direct role of collagen glycation in bone fracture.Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.Diabetes and Its Effect on Bone and Fracture Healing.Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans.Structural strength of cancellous specimens from bovine femur under cyclic compression Material heterogeneity in cancellous bone promotes deformation recovery after mechanical failure Raman spectroscopy demonstrates prolonged alteration of bone chemical composition following extremity localized irradiation Biomarkers of inflammation and innate immunity in atrophic nonunion fracture.The contribution of collagen crosslinks to bone strength.Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.Musculoskeletal Impairments Are Often Unrecognized and Underappreciated Complications From Diabetes.Review: The diabetic bone: a cellular and molecular perspective.Collagen modifications in postmenopausal osteoporosis: advanced glycation endproducts may affect bone volume, structure and quality.Bone's Material Constituents and their Contribution to Bone Strength in Health, Disease, and Treatment.Bone Material Properties and Skeletal Fragility.Even with rehydration, preservation in ethanol influences the mechanical properties of bone and how bone responds to experimental manipulation.The relative contributions of non-enzymatic glycation and cortical porosity on the fracture toughness of aging bone.Postnatal Development of the Murine Notochord Remnants Quantified by High-resolution Contrast-enhanced MicroCT.Metabolic transit of N(ε)-carboxymethyl-lysine after consumption of AGEs from bread crust.Effects of preexisting microdamage, collagen cross-links, degree of mineralization, age, and architecture on compressive mechanical properties of elderly human vertebral trabecular bone.The effect of aminoguanidine (AG) and pyridoxamine (PM) on ageing human cortical bone.Age-Related Effects of Advanced Glycation End Products (Ages) in Bone Matrix on Osteoclastic Resorption.

P2860

Q27025025-0EEDED59-5C9C-44BC-A721-0A277364FCD7 Q28482286-9AD36CA4-E99A-445C-8647-281D0A7FF24E Q28541226-D22A0697-0580-4FE7-8025-FB3FCEFFAA9F Q30433563-6986995B-AD4B-4041-A414-DCB0493A176C Q33788007-FD5B43F7-D416-49C7-A58D-3719EA708B22 Q34004460-969E073F-C0A7-4238-9E6A-D163FCD5C7A3 Q34606313-AC18569A-229F-4B04-A71C-E3899880EA79 Q34614556-290DA598-A608-41C7-A123-542DCCDA6C34 Q35002114-B6D0A5ED-5DDF-4BAA-8D7F-19BC69B5FA12 Q35171248-74DD444A-1DBB-4108-96B2-727223ED12D8 Q35245623-95381AE7-2838-46DE-88F1-54B15FD6E85B Q35294412-91A89A95-CCA8-4AA9-A997-22E14E120538 Q35850476-D6967F04-90EA-443E-94DE-C88CF9B1BEC2 Q35962480-9743143A-C79E-4C01-B1B6-45013ECC845E Q35963018-BCD88AC5-20E1-4D9B-9C0C-250646379A08 Q36010491-E4183C71-CD8D-4BD8-B699-BD67C43593BC Q36153043-1B87BBBE-D0E1-445C-A4A8-71D0285DC3D6 Q36282834-082E631C-2BCF-49AB-88DF-B8251EFFA39E Q36296930-CE38ACC1-FA0B-4A73-90B1-2FCCA18C31DC Q36372679-D83181A9-B4F8-45D7-9291-B1F782357852 Q36407732-09F16576-0F9E-4429-B00E-F8D1A49C436B Q36435839-E821C309-A29A-42A3-8A65-5EF0C407EA26 Q36543149-3B6F324E-84E8-409D-918A-A5CDCDE5C41A Q36710698-83C938D0-0A83-450A-A7AC-DA1962B11E2D Q37212472-327AB08E-1F49-4B14-A67A-3043452CFC35 Q37233069-12CC4110-4FDE-4BD8-B1F7-1C3209B2571E Q37404948-115D2D67-CEF2-431A-90F4-B5E2071345B2 Q37406648-C997B990-7305-43D5-B8A8-3438EB9F4761 Q37459539-46478413-87DC-4010-9F53-9C69EF017333 Q37858842-5777DCEF-0F4B-448A-B7C4-E5F81D293240 Q38216337-E2E92F38-5EBA-4031-A187-14AE5F9F3092 Q38364893-7A20422E-7759-4FD8-9EDB-E3976F89C4EA Q38458050-755B6099-8904-4740-B5EE-F2B94016E753 Q39037475-B390902F-999A-4488-AEA4-FC4C23C3B7AF Q42161678-384DB26B-C57B-4F46-87A4-5860D67215DE Q42657055-23D4C929-EC4D-495D-B754-F7B1ABFCB3A1 Q43968558-D7CC508F-7E54-46C6-AC86-1FC5DCAFBB9D Q46295396-750CE157-5638-44BE-B589-EE9F9C0CA524 Q47549644-0C592657-D54A-4FF2-A66E-9E6B171C80C1 Q48155040-B8AA2952-91A7-49B5-AF16-DDF8A3637D30

P2860

Non-enzymatic glycation alters microdamage formation in human cancellous bone.

http://www.wikidata.org/entity/Q35429148

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Non-enzymatic glycation alters microdamage formation in human cancellous bone.

@ast

Non-enzymatic glycation alters microdamage formation in human cancellous bone.

@en

type

label

Non-enzymatic glycation alters microdamage formation in human cancellous bone.

@ast

Non-enzymatic glycation alters microdamage formation in human cancellous bone.

@en

prefLabel

Non-enzymatic glycation alters microdamage formation in human cancellous bone.

@ast

Non-enzymatic glycation alters microdamage formation in human cancellous bone.

@en

P1433

Q35429148-C3C36EE8-EC93-4B56-80C4-BEF734A0E23C

P1476

Q35429148-0A0E8205-7BC5-4110-8D29-9C72F187BBBF

P2093

Q35429148-8B021C34-C8B4-47AB-B423-0DE9808ABC7E

P2860

Q35429148-025F83C9-AF17-41FB-AB2F-8F13FAEACF9C

Q35429148-05584751-1317-44C6-8C82-9F9EF4462618

Q35429148-07DEBBC9-4DC5-4E2E-965E-8F73ECC8A8FF

Q35429148-105E0678-FDE1-466F-AF64-64A33DFD72FD

Q35429148-261CB8ED-7C6B-4A9B-8511-7DBB6129B976

Q35429148-301B116E-FE5E-4F2E-A77C-FCC2E4819B5F

Q35429148-4E28FA6C-92FA-4B8F-9D17-6EDDD953C77D

Q35429148-58E7A2B1-2ED0-433B-9F6A-ED6921545A97

Q35429148-5B7FA417-67FD-43A4-A58E-60DA3381168A

Q35429148-64F5F989-D4AD-4DA5-93B3-561C87158E37

P304

Q35429148-C387C44A-523C-4FC8-B741-0881C494114E

P31

Q35429148-EED51F66-839C-4D74-851C-5E9D3832405A

P356

Q35429148-836FAF06-9A06-4C21-AD70-D7F90EF4F0DD

P433

Q35429148-39EA342E-4A4B-46D6-8262-19E0A3DD1BC4

P478

Q35429148-E2EB0A40-0596-4813-846C-3A00DD899804

P50

Q35429148-059980BE-D94B-4FF3-B582-026B2BF32200

P577

Q35429148-35434111-D5B8-440E-BA75-233C2E5C4496

P5875

Q35429148-4EC712CC-5BDE-4B1F-92EA-760DAA8AF6CB

P698

Q35429148-F3CABDAF-BFDF-4C9A-B2CA-1CFFFBFF89E4

P932

Q35429148-B5FEC888-8FB9-4FD3-B4F2-A420B2008146

P356

J.BONE.2009.09.003

P1433

P1476

Non-enzymatic glycation alters microdamage formation in human cancellous bone

@en

P2093

D Vashishth

http://www.w3.org/2001/XMLSchema#string

P2860

A non-invasive in vitro technique for the three-dimensional quantification of microdamage in trabecular bone

In vivo diffuse damage in human vertebral trabecular bone.

Age-related mineralization heterogeneity changes in trabecular bone of the proximal femur.

Influence of nonenzymatic glycation on biomechanical properties of cortical bone.

Three-dimensional confocal images of microdamage in cancellous bone.

Does microdamage accumulation affect the mechanical properties of bone?

Effects of non-enzymatic glycation on cancellous bone fragility.

Diabetes Mellitus: Does it Affect Bone?

Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links.

Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.

P304

148-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BONE.2009.09.003

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26805810

http://www.w3.org/2001/XMLSchema#string

P698

19747573

http://www.w3.org/2001/XMLSchema#string

P932

4398022

http://www.w3.org/2001/XMLSchema#string